Research published in Frontiers in Endocrinology found that GLP-1 receptor agonists can improve liver health in people with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD)
While Ozempic is a GLP-1 agonist, Mounjaro is classified as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, or dual GIP/GLP-1 agonist, meaning it targets an additional pathway to help control blood sugar (and as a side effect, help with weight loss)
Three steps between you and lasting results
The most effective care combines medical support, therapy and recovery coaching, tailored to each person's goals." For employers, Harrison said, this means coordinating GLP-1 coverage with screening for alcohol use disorder, access to counseling or treatment programs and ongoing monitoring and support through EAPs or specialty vendors
IBD, is also frequently associated with low bone mineral density
Free telemedicine consults!